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ABSTRACT
Objective: Few studies have reported on nutritional
recovery, survival and growth among severely malnour-
ished children with HIV. This study explores nutritional
recovery in HIV-infected and HIV-uninfected children
during inpatient nutrition rehabilitation and 4 months of
follow-up.
Design: Prospective cohort study.
Setting: Lilongwe district, Malawi.
Main outcome measures: Weight gain, anthropo-
metrics.
Results: In our sample of 454 children with severe acute
malnutrition (SAM), 17.4% (n = 79) of children were HIV
infected. None of the children were on antiretroviral
therapy upon admission. Among the HIV-infected children,
35.4% (28/79) died, compared with 10.4% (39/375) in
HIV-uninfected children (p,0.001). All children who
survived achieved nutritional recovery (.85% weight for
height and no oedema), regardless of HIV status. HIV-
infected children had similar weight gain to HIV-uninfected
children (8.9 vs 8.0 g/kg/d, not significant (NS)). Mean
increases in z-scores for both subscapular (2.72 vs 2.69,
NS) and triceps (1.26 vs 1.48, NS) skinfolds were similar
between HIV-infected and HIV-uninfected children,
respectively, during nutrition rehabilitation. 362 children
were followed for 4 months, at which time mean weight
for height z-score was similar in HIV-infected and HIV-
uninfected children (20.85 vs 20.64, NS).
Conclusions: HIV-infected children with SAM have
higher mortality rates than HIV-uninfected children.
Among those who survive, however, nutritional recovery
is similar in HIV-infected and HIV-uninfected children.
Case fatality rates among children with severe
acute malnutrition (SAM) are often as high as
20–30%,1–4 particularly among children with SAM
complicated by infection. HIV infection is common
in children with SAM in sub-Saharan Africa,
particularly in urban referral hospitals.1 3–10
Severely malnourished children with HIV infection
have an increased risk of mortality compared with
their HIV-uninfected counterparts (relative
risk = 3.41, 95% CI 2.24 to 5.20).4
Few studies, however, have reported on nutri-
tional recovery, survival and growth among
severely malnourished children with HIV. Two
studies in Malawi, of children with SAM treated as
outpatients with ready to use therapeutic food,
reported nutritional recovery. In the first study,
nutritional recovery, as defined by achieving a
weight for height z-score (WHZ) .20.5, was 78%
(202/260) among the children overall and 59%
(46/78) among HIV-infected children.9 In the
second study, 56% (52/93) of HIV-infected
children achieved nutritional recovery, defined as
100% weight for height index (W/H).8 Sandige et al
(2004) reported a significantly slower weight gain
in HIV-infected children compared with HIV-
uninfected children (mean (SD) 3.6 (4.7) g/kg/d
vs 5.6 (4.0) g/kg/d, p,0.001). These two studies
however, do not give a complete picture of
nutritional recovery in HIV, as children were
recruited after a period of hospital stabilisation.
Mortality was not described during this period.8 9
In view of the limited data from long-term
community follow-up of children with SAM and
HIV after discharge, we measured nutritional
recovery in HIV-infected and HIV-uninfected
children during inpatient rehabilitation and after
4 months of follow-up.
METHODS
We carried out a prospective study, measuring
survival and nutritional recovery during nutritional
rehabilitation, on a cohort of HIV-infected and
HIV-uninfected children with SAM. The study
was carried out at three nutritional rehabilitation
units (NRUs) in Lilongwe District, central Malawi;
two belonging to the Ministry of Health (MOH)
and one to the Christian Health Association of
Malawi (CHAM). Kamuzu Central Hospital NRU
is situated in Lilongwe, capital city of Malawi, and
is a 1000-bed referral hospital for Malawi’s central
region. The other two NRUs are situated in rural
areas; one, with 200 beds, at St Gabriel’s mission
hospital; the other, with 100 beds, at Mitundu
Community Hospital.
All children aged between 6 and 60 months,
with either a W/H of less than 70%,11 the presence
What is already known on this topic
Among children with severe acute malnutrition,
HIV-infected children are more likely to die than
HIV-uninfected children; at particular risk of mor-
tality are those HIV-infected children with advanced
disease and low CD4%.
What this study adds
HIV-infected children with severe acute malnutrition
who survive nutritional rehabilitation achieve and
maintain nutritional recovery as well as HIV-
uninfected children.
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of bilateral pitting oedema or with a mid-upper arm circumfer-
ence of,11 cm, were eligible for recruitment.12 Written consent
to join the study and to test the child for HIV was obtained
from all guardians who agreed to have their children join the
study (95% of guardians were mothers). Testing usually
occurred within the first 3 days of admission to the NRU. All
children, for whom consent to join the study was obtained, had
blood collected for HIV and CD4 testing.
Severely malnourished children were recruited at the out-
patients department and referred for therapeutic feeding in the
NRU.12 A small proportion of children with SAM had serious
medical complications; they were referred directly to the
paediatric ward for medical and nutritional care, and were not
recruited into the study. Children who had been initially
admitted to the paediatric ward but subsequently transferred to
the NRU were recruited to the study. Five point five per cent
(25/454) of children who were admitted to the NRU, and
became part of our study but who subsequently developed
serious medical complications were transferred to the paediatric
ward and were lost to follow-up.
Nutritional rehabilitation, using F75 and F100, of all severely
malnourished children, was carried out in accordance with the
Malawi MOH Guidelines for the Management of Severe Acute
Malnutrition13; adapted from the World Health Organization
(WHO) Guidelines for the Inpatient Treatment of Severely
Malnourished Children.12 All children received an equal standard
of care regardless of their guardian’s consent or refusal to join
the study.
Nutritional rehabilitation is carried out in three phases.12 13
Children were weighed on admission and daily during phase I
and transitional phase, then on alternate days during phase II
using a paediatric Salter scale with an accuracy of 100 g. Height
measurements were taken on admission and discharge from the
NRU using a paediatric height board with an accuracy of 1 mm.
Weight change in oedematous children was measured from
lowest weight to discharge weight and in marasmic children
from admission weight to discharge weight. Skinfold thickness
measurements were taken at two sites as a proxy for body fat.
Subscapular and triceps skinfold thickness was measured using
a Holtain Tanner/Whitehouse Caliper (Holtain Ltd, Crosswell,
UK), on admission and repeated on discharge from the NRU,
with an accuracy of 1 mm. Three readings for each skinfold
measurement were taken each time and the mean of the three
readings was used for calculations.
Children were discharged from the NRU back into the
community upon reaching nutritional recovery (W/H of 85%
and no presence of oedema for 10 days). Their nutritional
rehabilitation and monitoring continued at the supplementary
feeding clinics for 4 months, where they were seen every
fortnight to receive food rations (5 kg corn soya blend mixed
with 500 ml of cooking oil) together with routine nutritional
and medical assessment. Children were visited at home for
follow-up if they failed to attend the supplementary feeding
clinics. Urban and rural households were defined by local
community-based health staff using addresses, maps and local
knowledge.
Cotrimoxazole was prescribed in Malawi during this period
for prophylaxis and treatment of known HIV-exposed and HIV-
infected children, although there were some interruptions in
supply. Paediatric antiretroviral therapy (ART) was not avail-
able in Malawi when the study commenced, and none of the
children were on ART upon study admission. All mothers were
offered voluntary counselling and testing (VCT); however,
entry into the study required them to accept an anonymous,
linked HIV test for themselves and their child. In May of 2006,
with the advent of paediatric ART availability, the study testing
protocol was changed to require new study participants to
accept HIV testing. HIV-infected mothers and children were
referred for HIV treatment and care under MOH guidelines.
Twelve HIV-infected children were recruited after this change
in guidelines. None of these children were on ART upon NRU
discharge. It is unknown how many of these children were
initiated in ART under MOH care after discharge from the
NRU. All children were treated for SAM regardless of the uptake
of VCT by their guardians.
HIV was diagnosed in children aged .18 months using two
rapid tests: Abbott Determine HIV 1 and 2 (Abbott
Laboratories, Abbott Park, Illinois, USA) and Trinity
UNIGOLD HIV 1 Rapid (Trinity Biotech, Bray, UK). ‘Positive’
and ‘negative’ results were those with concordant results for
both tests. Discordant results were confirmed using a Bio-Rad
Western Blot. HIV diagnosis for children aged ,18 months was
carried out once using DNA polymerase chain reaction, using
Roche Amplicor HIV-1 DNA assay (version 1.5) (Roche
Diagnostics, Pleasanton, California, USA). CD4 count
(expressed as percentage of total lymphocytes) was measured
using a Beckman Coulter EPICS II machine (Beckman Coulter,
Fullerton, California, USA). HIV and CD4 testing was carried
out by the University of North Carolina Laboratories in
Lilongwe, Malawi.14
The study was carried out from May 2005 to November 2006,
recruiting a total of 454 children. All data were double entered
in Malawi, and checked for consistency. Ethical approval was
given by the National Health Sciences Research Committee of
Malawi.
STATISTICAL ANALYSIS
Weight and height values were transformed to weight for age z-
score (WAZ) and weight for height z-score (WHZ) using Epi-
Info (version 3.4.3), based on the WHO/Centre for Disease
Control National Center for Health Statistics growth refer-
ences.11 Skinfold measurements were transformed into z-scores,
based on the new WHO growth references (WHO, 2007), using
the lmsGrowth programme (version 2.4).
Of a sample of 454 children, 14 children had missing birth
date data, meaning WAZ could not be calculated for 14 children
and skinfold data could not be calculated for 12 children.
Records for presence of oedema were missing for two children.
Additionally, 91 children had no skinfold measurements at
admission and were excluded from the initial comparisons.
Furthermore, no skinfold data were available at discharge for
another 51, and a further six children who died or were
transferred to the paediatric ward, leaving a final sample of 258
children for comparing the change of skinfold data between
admission and discharge.
Data analysis was carried out using SPSS version 14.0.
Comparisons between groups were analysed using Chi-square
and between means using the Mann–Whitney U test.
RESULTS
There were 621 eligible children admitted to the NRUs.
Eighteen point five per cent (115/621) of carers declined. In
10% (52/506) of children HIV diagnosis was not made, either
because they died before testing (22/52) or had clotted blood
samples (30/52). Thus, there were 454 children with known
HIV results.
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In our sample of 454 children with SAM, 17.4% (n = 79) of
children were HIV infected. Among the HIV-infected children,
35.4% (28/79) died during nutritional rehabilitation, compared
with 10.4% (39/375) in HIV-uninfected children (p,0.001). All
children who survived achieved nutritional recovery, regardless
of HIV status (fig 2).
HIV-infected children weighed less on admission and had a
lower oedema-free weight (table 1) (both p,0.01). Overall,
86.7% (392/452) of children were oedematous, and fewer HIV-
infected children had oedema than HIV-uninfected children
(56/79, 70.9% vs 336/373, 90.1%, p = 0.01). HIV-infected
children had significantly lower values of WHZ and WAZ
(both p,0.01), and lower triceps skinfold z-scores (p = 0.018).
Subscapular skinfold z-score values were lower for HIV-infected
children but this difference was not statistically significant.
Oedematous children gained weight significantly less quickly
(7.9 g/kg/d, n = 315) than marasmic children (10.7 g/kg/d,
n = 45) (p = 0.001). There was no significant difference in rate
of weight gain for marasmic HIV-infected (10 g/kg/d, n = 14) or
marasmic HIV-uninfected children (11.1 g/kg/d, n = 28). HIV-
infected and HIV-uninfected children with oedema also had
similar rates of weight gain (8.6 g/kg/d, n = 28 vs 7.7 g/kg/d,
n = 284, not significant (NS)).
HIV-infected children gained more weight than HIV-unin-
fected children (1.45 kg vs 1.21 kg; p = 0.03). Although HIV-
infected children had a longer stay in the NRU (28.8 days vs
24.3 days; p = 0.03), their rate of weight gain was slightly
higher (8.9 g/kg/d vs 8.0 g/kg/d, NS). CD4 count data were
available for 65 HIV-infected children; 45/65 children had a
CD4% of ,20%. HIV-infected children with a CD4% ,20%
gained weight less rapidly than those with a CD4% .20%
(7.6 g/kg/d vs 11.9 g/kg/d, NS).
Using the 2006 WHO recommendations for starting paedia-
tric ART according to CD4% by child age group,15 ART is
recommended for children: (11 months of age with CD4%
,25%; 12–35 months with CD4% ,20%; and 36–59 months
with CD4% ,15%. Sixty-nine point two per cent (45/65) of
HIV-infected children with SAM required ART (7/9
(11 months, 32/48 12–35 months and 6/8 36–59 months).
HIV-infected children who required ART by WHO criteria
had a mean weight gain of 7.6 g/kg/d (SD 4.4) while those who
did not yet qualify for ART gained 11 g/kg/d (SD 6.1) (NS).
Skinfold data of children who recovered nutritionally are
shown in fig 3. Subscapular skinfold z-scores were similar on
admission and discharge between HIV-infected and HIV-
uninfected children. HIV-infected children, however, had
significantly lower triceps skinfolds than HIV-uninfected
children on admission. Despite this initial difference, the mean
change in z-score values for both subscapular and triceps
skinfolds was similar for HIV-infected and HIV-uninfected
children.
Eight point five per cent (34/398) of children were lost to
follow-up after discharge from the NRU (12 HIV infected, 22
HIV uninfected). Three hundred and sixty-four children were
followed for 4 months following discharge. Eleven children died
during the 4 months of follow-up after discharge from the NRU
(four HIV infected, seven HIV uninfected). At 4 months of
follow-up, mean WHZ was similar in both HIV-infected and
HIV-uninfected children (20.85 vs 20.64, NS). From admission
Table 1 Anthropometrics by HIV status on admission to the study
HIV positive HIV negative Difference
No Mean SD No Mean SD p Value
Age (months) 79 21.6 10.5 375 23.6 10.0 0.052
Weight (kg) 79 6.56 1.70 374 7.45 1.94 ,0.001
Oedema-free weight (kg)* 70 6.27 1.48 361 7.36 1.77 ,0.001
WAZ admission 74 24.14 1.0 365 23.74 1.25 0.011
WHZ admission 79 22.74 1.11 374 22.29 1.42 0.007
MUAC{ 16 11.4 1.75 148 12.6 1.65 0.001
Triceps skinfold z-score 54 23.10 2.36 297 22.32 2.10 0.018
Subscapular skinfold z-score 54 24.56 3.63 297 23.98 2.77 0.3
*Oedema-free weight is defined as the lowest weight during admission.
{On admission MUAC was only taken for children who were .75 cm tall.
MUAC, mid upper arm circumference; WAZ, weight for age z-score; WHZ, weight for height z-score.
Figure 1 Outcome of nutritional rehabilitation.
Figure 2 Outcome of nutritional rehabilitation within the nutritional
rehabilitation unit.
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to 4 months of follow-up, WHZ increased by 1.94 z-scores
(SD 1.75) in HIV-infected children and by 1.64 z-scores
(SD 1.84) in HIV-uninfected children (NS). Furthermore, mid
upper arm circumference at follow-up was similar between
HIV-infected children (13.7 cm, SD 1.23) and HIV-uninfected
children (13.9 cm SD 1.39) (NS). Data on appetite during
community follow-up were available for 344 children; of these,
98.1% had good appetites (n = 341). Additionally, only three
children (0.9%) had relapsed and required re-admission.
DISCUSSION
Nutritional recovery was achieved in 79.7% (362/454) of
severely malnourished children overall, meeting international
minimum standards for recovery from nutritional rehabilitation
(.75%).16 However, this study shows clearly that HIV-infected
children were less likely to achieve nutritional recovery than
HIV-uninfected children overall; this is attributable to their
higher mortality. Nutritional recovery among the survivors was
similarly good among HIV-infected and HIV-uninfected chil-
dren. Anthropometric measurements for weight, weight for
height and skinfold data showed that HIV-infected children
were more malnourished than HIV-uninfected children on
admission, and were significantly less likely to survive.
Among those children who survive, however, nutritional
recovery and growth are similar for HIV-infected and HIV-
uninfected children. These gains were maintained over 4 months
of follow-up post-discharge from the NRU. Also, among
children who survived, HIV-infected and HIV-uninfected
children experienced similar improvements in triceps and
subscapular skinfolds.
We believe this to be an important finding, as it dispels the
common belief among many health workers that HIV-infected
children with SAM do not recover well. This research shows
that investing resources into nutritional rehabilitation can yield
benefits in child survival and growth. Furthermore, it is likely
that, with improved access to paediatric ART in sub-Saharan
Africa, nutritional recovery among HIV-infected children with
SAM will result in improvements in survival, nutritional
recovery and growth.17
In an earlier publication from the same cohort of children, we
reported that mortality was significantly higher in children with
lower CD4%.4 The present data show that surviving children
with low CD4%, and those who are eligible for ART according
to WHO 2006 guidelines, gained weight more slowly — most
likely the result of opportunistic infections and anorexia. It is
noteworthy that even among HIV-infected children with SAM
who achieved nutritional recovery, CD4% was low. This
underscores the importance of providing access to HIV and
CD4% testing as well as ART treatment for severely mal-
nourished children. In the absence of CD4% monitoring,
however, these data support using severe malnutrition as a
clinical criterion for paediatric ART initiation.16
Although ART may impact positively on nutritional recovery
for some HIV-infected children it is likely that some of the
children presenting with low CD4% and SAM complicated by
opportunistic infections will present with advanced disease, and
ART may be too late to impact on survival. Incorporating HIV
testing and treatment into growth monitoring and into
programmes for treatment of moderate malnutrition may help
to detect HIV infection at risk at an earlier stage, and improve
outcomes.
CONCLUSION
HIV-infected children with SAM have higher mortality rates
than HIV-uninfected children. Among those who survive,
however, nutritional recovery is similar in HIV-infected and
HIV-uninfected children.
Our findings show that HIV-infected children can achieve
and maintain nutritional recovery. However, the majority of
those HIV-infected children recovering from SAM have a low
CD4% and require ART. Nutrition rehabilitation programmes
are an important entry point for HIV care, and in order to
achieve further gains in child growth and survival among HIV-
infected severely malnourished children, it is essential to
Figure 3 Outcome of nutrition
rehabilitation in HIV-infected and HIV-
uninfected children within the nutritional
rehabilitation unit.
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integrate HIV services into programmes for nutritional rehabi-
litation in high HIV prevalence settings. HIV testing, CD4
monitoring and treatment, including cotrimoxazole and ART,
should be universally available to children with SAM.
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